Nanophoria (private company)
		See something wrong or missing? Let us know
	
Offices:Milan
			
			Industry:BiotechHealth services
			Business model:B2B
			
			NanoPhoria is a pre-clinical stage biotech company from Italy that is developing a versatile, non-viral drug delivery platform based on inorganic nanoparticles.
					Investors:
					
						
							we tracked 4 investors
						
					
				
				
					You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
					Investments 101.62M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Nanophoria
| Name | Criteria | |
|---|---|---|
|  | AbolerIS Pharma 52% | 
 | 
|  | Acesion Pharma 52% | 
 | 
|  | AFYX Therapeutics 52% | 
 | 
|  | Algenex 52% | 
 | 
|  | Antag Therapeutics 52% | 
 | 
|  | Arthex Biotech S.L. 52% | 
 | 
|  | Atai Life Sciences 52% | 
 | 
|  | Biofidelity 52% | 
 | 
|  | BoneSupport 52% | 
 | 
|  | CatalYm 52% | 
 | 

 Belgium
 Belgium Netherlands
 Netherlands Austria
 Austria Switzerland
 Switzerland Estonia
 Estonia Finland
 Finland Iceland
 Iceland Latvia
 Latvia Lithuania
 Lithuania Norway
 Norway Ireland
 Ireland Portugal
 Portugal